STOCKHOLM & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alprolix® (rFIXFc) Approved in the EU for the Treatment of Haemophilia B; First Fc Fusion Therapy Approved for haemophilia B in the EU to Provide Extended Protection Against Bleeds
![]()
↧